Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07421154 · ClinicalTrials.gov registry record · NA
Study of a Smart Sharps Disposal Device in Patients With Hemophilia
A NA study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT07421154: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT07421154 is a NA study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07421154, a NA study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
Primary Outcome
% from baseline to active phase that patient adheres to using needle disposal
Interventions
- OTHER The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2026-09-30 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What is known before NCT07421154 opens enrollment
NCT07421154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient. is the first listed.
NCT07421154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07421154 about?
NCT07421154 is a clinical study titled "Study of a Smart Sharps Disposal Device in Patients With Hemophilia". This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
What is the current status of trial NCT07421154?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2026-09-30. Estimated completion is 2027-01-30.
What interventions are being tested in trial NCT07421154?
The interventions under investigation include: The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient. (OTHER).
Who is sponsoring clinical trial NCT07421154?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07421154's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI